Sedation medicine for premature babies on breathing machines
Treatments studied
Part of Brain & nervous system, Mental health, Pain clinical trials.
This trial tests a medicine called dexmedetomidine to keep premature babies calm and comfortable while they are on a breathing machine. It may help reduce pain and stress for your baby during this difficult time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born before 32 weeks of pregnancy
- Your baby is currently on a breathing machine and is expected to need it for more than 24 hours
- The breathing machine was started less than 72 hours ago
- You give your permission for your baby to join the trial
- Your baby is not in another study involving pain or sedation medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two sedative medicines, dexmedetomidine and midazolam, to see which one helps preterm babies on a ventilator breathe on their own sooner. Your baby may be eligible if they were born very early and need medicine to relax while on the breathing machine.
This study tests a drug called dexmedetomidine to help sedate children who need a breathing machine for more than 12 hours. It may reduce confusion (delirium) compared to usual sedatives.
This study tests a nose spray medicine (dexmedetomidine) to help reduce pain and discomfort in premature babies who need eye exams for retinopathy of prematurity (a condition that can affect vision). The goal is to see if the spray works better than the usual care for calming babies during the exam.
This study tests an early sedation medicine called dexmedetomidine in patients 65 and older who need a breathing tube. It may help reduce confusion and time on the machine compared to usual care.
This study tests two different pain medicines (dexmedetomidine and morphine) given to newborns during cooling therapy, which is a treatment to help reduce brain injury. The goal is to see which medicine works better for comfort and safety.
This study tests a combination of two medicines (dexmedetomidine and esketamine) to help ICU patients who are on a breathing machine feel calm and have less pain. The goal is to find a safe and effective way to keep patients comfortable while they recover.
Hear when a new Neonatal Respiratory Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.